Home » FDA Clears Greystone's Epi-Max for Sale in the U.S.
FDA Clears Greystone's Epi-Max for Sale in the U.S.
Greystone Medical announced that it has received FDA clearance to market and sell Epi-Max, a wound care product created for the treatment of diabetic skin ulcers and other conditions. The FDA cleared Epi-Max as a combination product, one of the few advanced wound care products that contains both a drug and a device.
()a href="http://www.primezone.com/newsroom/?d=78457" target="_blank">PrimeZone
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May